Kairos Pharma (KAPA) Q4 2024 Earnings

14NovConfirmed
Q1 1
Q4 2024
-0.05
-0.04
-0.03
-0.02

Details

Expected EPS
-0.02
Actual EPS
-0.05
Surprise EPS
-0.03
Surprise Percent
+150%

Description

Kairos Pharma (KAPA) has reported earnings of -0.05 per share for Q4 2024.

0 Comments

Share your thoughts